A 52-year-old male with severe gastrointestinal graft-versus-host disease (GVHD), developed dyspnea and irreversible airflow obstruction, 11 weeks post-allogeneic bone marrow stem cell transplantation. Based on the clinical picture and presence of 'mosaic attenuation' pattern on chest high-resolution computerized tomography (HRCT), he was presumed to have bone marrow transplantation-related bronchiolitis obliterans. Postmortem examination revealed invasive airway aspergillosis with no evidence of bronchiolitis obliterans.Bone Marrow Transplantation (2002) 29, 711-713. DOI: 10.1038/sj/bmt/1703553 Keywords: airway obstruction; aspergillus; bronchiolitis obliterans; bone marrow transplantation; graft-versushost disease Allogeneic bone marrow transplantation (BMT) has been consistently associated with a high incidence of pulmonary complications, such as opportunistic infections, toxic effects of chemoradiotherapy, and inflammatory lesions associated with graft-versus-host disease (GVHD). About 15% of patients after allogeneic BMT develop post-BMT bronchiolitis obliterans. 1 We present a patient in whom invasive airway aspergillosis was manifested by severe irreversible obstructive airway disease, mimicking post-BMT bronchiolitis obliterans.
Allogeneic bone marrow transplantation (BMT) has been consistently associated with a high incidence of pulmonary complications, such as opportunistic infections, toxic effects of chemoradiotherapy, and inflammatory lesions associated with graft-versus-host disease (GVHD). About 15% of patients after allogeneic BMT develop post-BMT bronchiolitis obliterans. 1 We present a patient in whom invasive airway aspergillosis was manifested by severe irreversible obstructive airway disease, mimicking post-BMT bronchiolitis obliterans.
Case report
A 52-year-old male with chronic myelogenous leukemia underwent allogeneic peripheral blood stem cell transplantation from his major histocompatibility complex (MHC) identical sister, during second chronic phase after a lymphoblastic crisis. Routine pulmonary evaluation prior to transplantation included normal high resolution com- puterized tomography (HRCT) of the chest, with normal spirometry and lung volumes and a mildly decreased carbon monoxide transfer factor (TL CO ) (70%).
Conditioning prior to allogeneic BMT consisted of oral busulfan 4 mg/kg p.o. in divided doses daily for 3 days (total dose 12 mg/kg), with intrathecal methotrexate (12.5 mg) and Ara-C (50 mg), followed by infusion of allogeneic peripheral blood stem cells (14 ϫ 10 8 cells/kg) on day 0.
At week +8 after transplantation, the patient's condition deteriorated with development of paroxysmal abdominal pain and diarrhea, marked hypoalbuminemia and elevated liver enzymes. Endoscopic biopsies obtained from the stomach and the duodenum revealed epithelial atrophy with necrosis and mucosal ulceration of the intestinal mucosa, accompanied by few apoptotic epithelial cells. Based on clinical and histologic findings, a diagnosis of chronic GVHD was made and the patient received a course of methylprednisolone, followed by prednisone at a dose of 50 mg daily. As there was unsatisfactory improvement in his symptoms, cyclosporin A was added to his immunosuppressive regimen, followed by thalidomide (200 mg/kg). The patient developed fever, and sputum culture yielded Klebsiella pneumonia, which was treated by ticracillinsulbactam. At this stage, prophylactic treatment against cytomegalovirus with ganciclovir three times weekly and intravenous immunoglobulin were added, as well as amphotericin B at a low daily dose of 10 mg until week +10.
At week +11 after transplantation, the patient developed jaundice and progressive dyspnea. The chest and abdomen were normal on examination. However, extensive leg edema was noted. Pulmonary function tests revealed a severe irreversible obstructive pattern on spirometry with a FVC of 2.31 l (55% of predicted value), FEV 1 of 1.25 l (37% pred), FEV 1 /FVC ratio of 54%, and FEF 25-75% of 0.52 L/s (14% pred). The airflow obstruction could not be relieved by bronchodilators. Lung volumes and TL CO were not determined due to the dyspnea causing patient discomfort. Chest CT demonstrated areas of increased hyperlucency adjacent to areas with normal or increased parenchymal markings, forming a 'mosaic attenuation' pattern (Figure 1 ), findings compatible with bronchiolitis obliterans.
Based on the clinical, physiological and radiological findings, the patient was assumed to have developed post-BMT bronchiolitis obliterans and treatment with high dose methylprednisolone was resumed. Within 5 days, the patient developed multiorgan failure with pancytopenia. He was treated with a combination of broad spectrum antibiotics and high-dose amphotericin B. Repeated plain chest films did not show any infiltrates. The patient died 13 weeks post transplantation. At postmortem examination, disseminated aspergillosis consisting of multiple microabscesses containing Aspergillus hyphae were detected, involving the heart, kidneys and stomach. Numerous sections of lung tissue were examined with no evidence of bronchiolitis obliterans. The bronchioles were markedly dilated and some were bronchiectatic. The lumena of some of the bronchioles were occluded by pus containing Aspergillus hyphae (Figure 2 ), while the more proximal bronchi, main bronchi and the trachea were spared. There was focal invasion by Aspergillus into the adjacent lung parenchyma. Remarkably, blood vessels were normal. In summary, the pulmonary findings consisted of invasive airway aspergillosis with no evidence of angioinvasive pulmonary aspergillosis.
Discussion
Besides the angioinvasive form of pulmonary aspergillosis, 2 invasive airway disease has been described in several forms: Aspergillus tracheobronchitis, 3 pseudomembranous tracheobronchitis 3, 4 and ulcerative tracheobronchitis. 5 Small airway Aspergillus infections have also been described. Logan et al 6 described seven patients with what they termed as invasive airway aspergillosis, three of whom after BMT showed evidence of invasive airway disease only. While gross pathology examination of the lung revealed small white bronchocentric nodules, microscopic examination showed dilatation of the bronchial lumen with exudate containing Aspergillus hyphae filling and occluding the bronchial lumen. The detection of the Aspergillus hyphae deep to the airway basement membrane is the hallmark of the invasive form of airway aspergillosis. 6 Radiologic findings in patients with invasive airway aspergillosis may consist of lobar consolidation, predominantly peribronchial with centrilobular nodules. However, areas of 'ground-glass' with areas of hyperlucency and hyperinflation, creating mosaic pattern of attenuation may be seen as a sole finding, 6 similar to patients with bronchiolitis obliterans.
In the present report, we describe a patient with evidence of invasive airway aspergillosis with a new-onset nonreversible airway flow obstruction evident on spirometry, attributed to the fungal infection. Notably, a new obstructive airway abnormality on spirometry has not yet been described in connection with invasive airway aspergillosis. However, such irreversible obstructive airway abnormality apparent 2-3 months onwards following BMT, is typical of post-BMT bronchiolitis obliterans.
Post-BMT bronchiolitis obliterans and invasive aspergillosis may coexist. It remains to be determined whether transbronchial biopsy may be sufficient to make this diagnosis of invasive airway aspergillosis, or whether open lung biopsy will always be required. The present case suggests that in an immunocompromised patient with a new obstructive airflow abnormality, the possibility of invasive airway aspergillosis should be considered, particularly in a patient prone to invasive fungal disease, for example, following BMT.
